Parameter | Treatment | Baseline | Pulmonary hypertension | |
---|---|---|---|---|
 |  |  | Pre-inhalation | 5 minutes after inhalation |
Mw (mWatt·s/ml) | Iloprost | 8.29 ± 1.66 | 10.67 ± 2.45* | 8.08 ± 2.22 |
 | Control | 7.54 ± 1.06 | 9.01 ± 1.27* | 9.24 ± 2.69 |
Emax (mmHg/ml) | Iloprost | 1.10 ± 0.46 | 1.51 ± 0.74 | 1.20 ± 0.66 |
 | Control | 1.13 ± 0.62 | 1.29 ± 0.75 | 1.64 ± 0.95 |
LVEF (%) | Iloprost | 61 ± 5 | 63 ± 12 | 59 ± 13 |
 | Control | 57 ± 9 | 53 ± 7 | 50 ± 5 |
τ/RR (ms) | Iloprost | 0.06 ± 0.02 | 0.08 ± 0.02 | 0.07 ± 0.01 |
 | Control | 0.07 ± 0.01 | 0.07 ± 0.01 | 0.08 ± 0.02 |
β (ml-1) | Iloprost | 0.11 ± 0.03 | 0.11 ± 0.06 | 0.04 ± 0.03* |
 | Control | 0.11 ± 0.04 | 0.13 ± 0.09 | 0.09 ± 0.05 |
C (ml/mmHg) | Iloprost | 0.72 ± 0.23 | 0.60 ± 0.20 | 0.64 ± 0.27 |
 | Control | 0.88 ± 0.27 | 0.71 ± 0.25* | 0.66 ± 0.21* |
Ea (mmHg/ml) | Iloprost | 1.87 ± 0.51 | 1.68 ± 0.44 | 1.67 ± 0.50 |
 | Control | 1.80 ± 0.46 | 1.93 ± 0.55 | 1.95 ± 0.56 |
Emax/Ea | Iloprost | 0.60 ± 0.24 | 0.92 ± 0.50 | 0.69 ± 0.30 |
 | Control | 0.62 ± 0.24 | 0.67 ± 0.31 | 0.86 ± 0.48 |